Biocon Ltd
BSE:532523
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Biocon Ltd (532523) under the Base Case is INR per share.
Compared with the current market price of 366 INR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Biocon Does
Biocon Ltd is a biopharmaceutical company that develops and makes medicines for diabetes, cancer, and other long-term illnesses. It sells a mix of biologic drugs, biosimilars, generic formulations, and key ingredients used by other drug makers. The company also works in contract research and development through its services businesses, which support drug discovery and testing for other pharmaceutical firms.
- Headquarters
- India IN
- Employees
- 16 420
- IPO date
- Apr 17, 2004
Biocon has a narrow economic moat
Biocon Ltd has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysisBalance Sheet
Recent Events
Latest Earnings Call
Biocon framed the second half as an execution inflection, with biosimilar momentum, improving generics profitability and a recovering Syngene trajectory supporting commercial acceleration.
Open the earnings call- EPS
- ₹0.29
- Expected
- ₹1.04
- Surprise
- −72.1%
- Stock, day of the call
- +0.4%
Past 12 months
Continue BIOCON Research
Decided on Biocon? Get an email when BIOCON reaches the price you’d buy at. Free with an account.
Other Biocon listings
What is the Intrinsic Value of one BIOCON stock?
The intrinsic value for
Biocon Ltd (532523) under the Base Case is INR.
Is BIOCON stock undervalued or overvalued?
Compared with the current market price of 366 INR, the stock appears .